Others

Aurobindo Pharma Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

| Updated on May 24, 2019 Published on May 24, 2019

Sub: Analyst / Investor call
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that an analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended 31st March, 2019 is scheduled on 29th May, 2019 at 8:30 AM.
Please find attached the dial-in details of the call.

Pdf Link: Aurobindo Pharma Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Source : BSE - www.bseindia.com

Published on May 24, 2019
This article is closed for comments.
Please Email the Editor